Teneligliptin Hydrobromide Teneligliptin HBr CAS 906093-29-6 CAS 906093-29-6 Kuchena >99.5% (HPLC) DPP-4 Inhibitor Factory

Tsanangudzo Pfupi

Kemikari Zita: Teneligliptin Hydrobromide

Anoreva zvakafanana: Teneligliptin HBr

CAS: 906093-29-6

Kuchena:> 99.5% (neHPLC)

Chiyero: 99.5% ~ 102.0% (Anhydrous Substance)

Chitarisiko: White kana Off-White Powder

API DPP-4 inhibitor mukurapa Type 2 chirwere cheshuga

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name Teneligliptin Hydrobromide
Mashoko anoreva zvakafanana Teneligliptin HBr
Nhamba yeCAS 906093-29-6
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C22H32.5N6OSBr2.5
Molecular Weight 628.86
Brand Ruifu Chemical

Zvinotsanangurwa:

Items Sstandards Results
Characteristics White kana Off-White Powder Zvinoenderana
Identification Kubva IR Zvinoenderana
  By HPLC Zvinoenderana
Zvemumvura (KF) <6.00% 3.00%
Residue onIgnition <0.50% 0.10%
HeavyMetals (sePb) <20ppm Zvinoenderana
Related Substances Chero Kusachena Kumwechete: <0.10% 0.05%
  Zvose Zvisina Kuchena: <0.50% 0.15%
Kuchena / Analysis Method >99.5% (neHPLC) 99.85%
Assay 99.5% ~ 102.0% (Anhydrous Substance) 99.90%
Test Standard Enterprise Standard
Mhedziso The ProductTeereradkuMumbaStandard.

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

1

FAQ:

Application:

Teneligliptin Hydrobromide (CAS: 906093-29-6) is dipeptidyl peptidase-4 (DPP-4) inhibitor inoshandiswa kurapa rudzi rwechipiri chirwere cheshuga.Inobviswa kuburikidza nekubuda, uye ine hafu yehupenyu hwemaawa 24.2 mumuviri wemunhu.Teneligliptin ndeye DPP-4 inhibitor yakabvumidzwa muJapan muna 2012 kurapa chirwere cheshuga chechipiri.Yakawanikwa uye yakagadziridzwa naMitsubishi Tanabe Pharma pasi pezita rekutengesa Tenelia®.Zvakafanana nezvimwe zvakashambadzirwa DPP-4 inhibitors, teneligliptin yakatenderwa muzvidzidzo zvese uye QD dosing yakagadzira inogara kwenguva refu inhibitory chiito ichipokana neDPP-4 uye kuwedzera kweanoshanda GLP-1 mazinga, aine yakaderera zvakanyanya yerenal excretion.

Nyora meseji yako pano uye titumire kwatiri